Nearly 50% of RRMS patients progress to SPMS in a 10 year time period indicating a huge market potential. However in present scenario, not many drugs are approved in the SPMS market indicating a huge unmet need.
All anti CGRP molecules have displayed similar efficacy and safety during trials. The products are expected to gain majority shares in Migraine market given their superior efficacy and safety profiles as compared to the existing therapies.
When planning to hit a gym for fitness it is very important for both men and women to find appropriate gym fitness apparel that provides great flexibility and comfort to carry on the workouts or the exercises.